Spotlight

Spotlight

Debates, in-depth articles, and surprising profiles from ASH Clinical News

Transforming Ideas into Research Reality

Participants come to the ASH Clinical Research Training Institute with ideas and enthusiasm, and leave with new skills to conduct patient-oriented research. Just 20 years...

Demystifying the Lab: Cytogenetics

Clinical applications abound for the study of structural abnormalties in chromosomes. The first chromosomal abnormality discovered in cancer using cytogenetics is likely still one of...

Breaking Down Barriers, Building Up Trust

Clinical trial enrollment has lacked diversity since the start, but a global racial reckoning has brought new attention to overcoming discrimination. According to the most...

Pulling Back the Curtain: Tom DeLoughery, MD

In this edition, Tom DeLoughery, MD, talks about the approachability of hematologists, blending his interests in science and the outdoors through wilderness medicine, and...

What Is the Optimal Frontline Treatment for PTCL?

At the 2020 American Society of Hematology (ASH) Annual Meeting, researchers presented five-year results from the phase III ECHELON-2 trial, showing that patients with...

Pulling Back the Curtain: Claire McLintock, MD

In this edition, Claire McLintock, MD, discusses her work at the intersection of women’s health and hematology and her experience as president of the...

Pain Pointers

Early intervention and careful management are critical in the treatment of peripheral neuropathy Peripheral neuropathy is a common occurrence in patients with hematologic diseases, whether...

Improving Sickle Cell Disease Outcomes in Sub-Saharan Africa Starts With Screening

For patients with sickle cell disease (SCD) living in sub-Saharan Africa, early intervention drastically improves long-term health outcomes, but challenges around funding, training, and...

Gene Therapy: The Comeback Kid of Hematology Treatments?

Despite slow progress and unexpected setbacks, the future of gene therapy remains bright. Ashanthi de Silva was the first human to be treated successfully with...

Pulling Back the Curtain: Craig Cole, MD

In this edition, Craig Cole, MD, speaks about empowering patients to make treatment decisions, targeting racial disparities in myeloma, and more. Where did you grow...
Advertisement

Current Issue

July 2021 Bonus Mid-Year Edition, Volume 7 Issue 9

This issue features conversations with ASH Clinical Research Training Institute graduates, highlights from the virtual ASCO and EHA annual meetings, and more.

Block title